| Condition | Key Finding | Association | Board Exam Tip |
| Intrauterine Fetal Demise (IUFD) | Overlapping fetal cranial bones on ultrasound | Liquefaction necrosis/Fetal death for a long time | Suggests the fetus has been dead for an extended period. |
| Antiphospholipid Syndrome (APS) | Prolonged PT, Hypercoagulable state | Anti-cardiolipin, Lupus anticoagulant, {Anti-}_2{ glycoprotein} antibodies | Remember APS is hypercoagulable despite potentially prolonged PT labs. |
| TIPS Procedure | High PCWP ( 18) or low EF | Severe Heart Failure; Pulmonary Hypertension | These are absolute contraindications because the procedure increases preload/venous return dramatically. |
| Type 1 Diabetes (Acute Illness) | {Glucose} > 300 { mg/dL} and Nausea | Counter-regulatory hormones (Glucagon, Epi); DKA risk | Never stop basal insulin; only hold mealtime insulin. |
| Topic | Key Point | Context | Exam Relevance |
| DIC Lab Profile | {PT/PTT} , Platelets, {D-dimer} , Fibrinogen | Triggered by Tissue Factor release (e.g., IUFD, AML t(15;17)) | The most sensitive measure of consumption is the decrease in fibrinogen. |
| APS Prophylaxis | Low Dose Aspirin ({81 mg}) + LMWH | Pregnancy/High risk of thrombosis | Must be given throughout pregnancy and up to 6-12 weeks postpartum. |
| TIPS Procedure Management | Lactulose or Rifaximin | Preventing Hepatic Encephalopathy (HE) post-procedure | Lactulose acidifies the colon, trapping ammonia; Rifaximin is a non-absorbable antibiotic. |
| Insulin Adjustment | Continue Basal; Hold Mealtime | Type 1 Diabetes in acute illness/poor intake | Prevents hypoglycemia while maintaining basal coverage against counter-regulatory hormone surges. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient with IUFD presents days later with epistaxis and petechiae, showing elevated PT/PTT, low platelets, high D-dimer, and low fibrinogen. | Disseminated Intravascular Coagulation (DIC) | Necrotic tissue factor release from the placenta/fetus triggers massive coagulation consumption, leading to classic lab derangements. |
| A pregnant patient with unexplained recurrent losses has positive anti-cardiolipin antibodies on two separate occasions 12 weeks apart. | Antiphospholipid Syndrome (APS) | The diagnostic criteria require persistent positive antibody testing for at least one of the three specified antibodies over time. |
| A cirrhotic patient requires a TIPS procedure but has an ejection fraction of 25% and severe pulmonary edema. | Contraindication to TIPS: Severe Heart Failure | TIPS increases venous return/preload, which a failing heart cannot accommodate, precipitating acute decompensation (high PCWP). |
| A Type 1 diabetic is acutely ill and unable to eat for several days. The physician asks for insulin management advice. | Continue Basal Insulin; Hold Mealtime Insulin | Maintaining basal coverage prevents hypoglycemia from counter-regulatory hormone surges while holding mealtime insulin prevents precipitous drops due to lack of carbohydrate intake. |
| A patient with cirrhosis and refractory ascites is considered for a TIPS procedure, but has severe coagulopathy and high ammonia levels. | Contraindication to TIPS: Severe Hepatic Encephalopathy Risk | Bypassing the liver via TIPS diverts portal blood rich in neurotoxins (ammonia), risking acute HE exacerbation. |
| A patient with suspected APS presents with a prolonged PT despite being hypercoagulable. | Key Lab Trap/Concept of APS | The lab picture can be misleadingly anti-coagulated, but the underlying state is one of hypercoagulability due to antibody effects. |
| Key Features | Distinguishing Findings | Next Step |
| Recurrent unexplained fetal/early pregnancy losses; positive antibodies on two occasions 12 weeks apart. | Positive Lupus Anticoagulant and Anti-cardiolipin antibodies. | Low dose aspirin ({81 mg}) + LMWH prophylaxis throughout pregnancy. |
| Key Features | Distinguishing Findings | Next Step |
| Refractory ascites (multiple paracenteses/month); bleeding varices unresponsive to EGD. | Severe {EF} < 30\%; Pulmonary Artery Pressure > 45 { mm Hg}; High ammonia levels. | TIPS is indicated; DO NOT perform if contraindications are met. |
| Condition | Association | Mechanism | Clinical Significance |
| IUFD/DIC | Tissue Factor Release | Necrotic placental or fetal tissue releases thromboplastin. | Leads to consumption coagulopathy and DIC; monitor fibrinogen levels closely. |
| Antiphospholipid Syndrome (APS) | Low Dose Aspirin + LMWH | Anti-thrombotic prophylaxis preventing placental thrombosis. | Essential for reducing adverse maternal/fetal outcomes in high-risk pregnancies. |
| TIPS Procedure | Hepatic Encephalopathy Risk | Bypassing the liver's detoxification capacity via portal blood diversion. | Requires prophylactic use of lactulose or rifaximin; contraindicates procedure if HE is suspected. |
| Type 1 Diabetes (Illness) | Counter-regulatory Hormone Surge | Metabolic stress triggers glucagon, epinephrine release increased gluconeogenesis/lipolysis. | Risk of DKA and severe hypoglycemia if insulin regimen is improperly adjusted. |
| Term | Definition | Context | Example |
| Tissue Factor (Thromboplastin) | A potent initiator of the extrinsic coagulation cascade. | Released from necrotic tissue (e.g., placenta, AML blast cells). | Its release is central to the development of DIC. |
| Antiphospholipid Syndrome (APS) | A hypercoagulable state characterized by persistent antibodies against phospholipid-binding proteins. | Causes recurrent thrombosis and pregnancy morbidity. | Requires prophylaxis with LMWH/Aspirin in high-risk pregnancies. |
| TIPS Procedure | Transjugular Intrahepatic Porto-systemic Shunt; creating a shunt within the liver parenchyma. | Used to decompress portal hypertension (refractory ascites). | Contraindicated if severe heart failure or pulmonary hypertension is present. |
| Lactulose | A non-absorbable disaccharide used in GI management. | Treats hepatic encephalopathy by acidifying the colon and trapping ammonia ({NH}_3). | Given orally to reduce systemic ammonia levels. |
| Topic | Study Approach | Priority | Resources |
| Coagulation/DIC | Master the lab pattern (PT, Fibrinogen ) and the source of Tissue Factor. | High | Review board questions on DIC triggers (e.g., sepsis, trauma, obstetrics). |
| APS Management | Memorize the specific drugs ({81 mg} Aspirin, LMWH) and timing (throughout pregnancy/postpartum). | High | Use mnemonics for the three required antibodies: {A-C-L}, {LA}, {Anti-}_2{ glycoprotein}. |
| TIPS Contraindications | Create a flow chart linking severe heart failure, PH, and HE to absolute contraindication. | Medium-High | Visualize the physiological consequence: increased preload/toxin load overwhelming failing systems. |